|
| Tenofovir alafenamide fumarate Basic information |
Product Name: | Tenofovir alafenamide fumarate | Synonyms: | GS-7340 (fuMarate);L-Alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (1:1);N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-llanine 1-methylethyl ester (2E)-2-butenedioate (1:1);Tenofovir alafenamide fumarate (1:1 salt);Tenofovir alafenamide-19;Tenofovir impurity 42/Tenofovir Alafenamide Fumarate/isopropyl ((R)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-L-alaninate fumarate;tenofovir alafenamide fumarate (TAF);vemlidy | CAS: | 379270-38-9 | MF: | C25H33N6O9P | MW: | 592.55 | EINECS: | 223-388-5 | Product Categories: | | Mol File: | 379270-38-9.mol |  |
| Tenofovir alafenamide fumarate Chemical Properties |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | solubility | DMSO:68.0(Max Conc. mg/mL);114.56(Max Conc. mM) Ethanol:100.0(Max Conc. mg/mL);168.48(Max Conc. mM) Water:17.5(Max Conc. mg/mL);29.48(Max Conc. mM) | form | Powder | color | White to off-white |
| Tenofovir alafenamide fumarate Usage And Synthesis |
Uses | Tenofovir alafenamide fumarate is a newer, more effective prodrug used in combination with FTC that has recently been approved for the prevention of HIV transmission through the rectum. It is used to treat chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. |
| Tenofovir alafenamide fumarate Preparation Products And Raw materials |
|